» Articles » PMID: 38378880

Photoinactivation of Microorganisms Using Bacteriochlorins As Photosensitizers

Abstract

In recent years, some microorganisms have shown resistance to conventional treatments. Considering this increase in resistant pathogens, treatment alternatives are needed to promote greater treatment efficiency. In this sense, antimicrobial photodynamic therapy (aPDT) has been an alternative treatment. This technique uses a photosensitizer that is activated by light with a specific wavelength producing reactive species, leading to the death of pathogenic microorganisms. In this study, bacteriochlorophyll derivatives such as bacteriochlorin metoxi (Bchl-M) and bacteriochlorin trizma (Bchl-T) obtained from purple bacterium (Rhodopseudomonas faecalis), were evaluated as photosensitizers in the aPDT. Photodynamic inactivation (PDI) of the microorganisms Staphylococcus aureus, Micrococcus luteus, Candida albicans and Pseudomonas aeruginosa was investigated with both bacteriochlorins (Bchl-M and Bchl-T) at different concentrations (1, 15 and 30 µM for S. aureus; 1, 15, 30, 45, 60 and 75 µM for M. luteus; 30, 60, 90, 105, 120 and 150 µM for C. albicans; and 200 µM for P. aeruginosa) and different doses of light (20 and 30 J/cm for S. aureus and M. luteus; 30 and 45 J/cm for C. albicans; and 45 J/cm for P. aeruginosa) to inactivate them. Both photosensitizers showed good activation against S. aureus and for M. luteus, we observed the inactivation of these microorganisms at approximately 3 log, showing to be a good photosensitizers for these microorganisms.

Citing Articles

Illuminating the path: the role of photodynamic therapy in comprehensive periodontal treatment.

Al-Timimi Z Ir J Med Sci. 2025; .

PMID: 40029532 DOI: 10.1007/s11845-025-03924-5.


Antimicrobial Photodynamic Therapy: Self-Disinfecting Surfaces for Controlling Microbial Infections.

Dube E Microorganisms. 2024; 12(8).

PMID: 39203415 PMC: 11356738. DOI: 10.3390/microorganisms12081573.

References
1.
Casteel M, Jayaraj K, Gold A, Ball L, Sobsey M . Photoinactivation of hepatitis A virus by synthetic porphyrins. Photochem Photobiol. 2004; 80(2):294-300. DOI: 10.1562/2004-04-05-RA-134. View

2.
Dai T, Huang Y, Hamblin M . Photodynamic therapy for localized infections--state of the art. Photodiagnosis Photodyn Ther. 2009; 6(3-4):170-88. PMC: 2811240. DOI: 10.1016/j.pdpdt.2009.10.008. View

3.
Kholikov K, Ilhom S, Sajjad M, Smith M, Monroe J, San O . Improved singlet oxygen generation and antimicrobial activity of sulphur-doped graphene quantum dots coupled with methylene blue for photodynamic therapy applications. Photodiagnosis Photodyn Ther. 2018; 24:7-14. DOI: 10.1016/j.pdpdt.2018.08.011. View

4.
Gonzalez I, Palavecino A, Nunez C, Dreyse P, Melo-Gonzalez F, Bueno S . Effective Treatment against ESBL-Producing through Synergism of the Photodynamic Activity of Re (I) Compounds with Beta-Lactams. Pharmaceutics. 2021; 13(11). PMC: 8621492. DOI: 10.3390/pharmaceutics13111889. View

5.
Hassett D, Sutton M, Schurr M, Herr A, Caldwell C, Matu J . Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways. Trends Microbiol. 2009; 17(3):130-8. DOI: 10.1016/j.tim.2008.12.003. View